Literature DB >> 33879882

Long COVID's long R&D agenda.

Asher Mullard.   

Abstract

Entities:  

Year:  2021        PMID： 33879882     DOI： 10.1038/d41573-021-00069-9

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  7 in total

Review 1.  COVID-19 therapeutics: Challenges and directions for the future.

Authors:  Philip C Robinson; David F L Liew; Helen L Tanner; John R Grainger; Raymond A Dwek; Ronald B Reisler; Lawrence Steinman; Marc Feldmann; Ling-Pei Ho; Tracy Hussell; Paul Moss; Duncan Richards; Nicole Zitzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-06       Impact factor: 12.779

2.  Severity of COVID-19 and adverse long-term outcomes: a retrospective cohort study based on a US electronic health record database.

Authors:  Nick Jovanoski; Xin Chen; Ursula Becker; Kelly Zalocusky; Devika Chawla; Larry Tsai; Michelle Borm; Margaret Neighbors; Vincent Yau
Journal:  BMJ Open       Date:  2021-12-10       Impact factor: 3.006

3.  PASCLex: A comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes.

Authors:  Liqin Wang; Dinah Foer; Erin MacPhaul; Ying-Chih Lo; David W Bates; Li Zhou
Journal:  J Biomed Inform       Date:  2021-11-13       Impact factor: 8.000

Review 4.  Neurological manifestations of long-COVID syndrome: a narrative review.

Authors:  Maria-Ioanna Stefanou; Lina Palaiodimou; Eleni Bakola; Nikolaos Smyrnis; Marianna Papadopoulou; George P Paraskevas; Emmanouil Rizos; Eleni Boutati; Nikolaos Grigoriadis; Christos Krogias; Sotirios Giannopoulos; Sotirios Tsiodras; Mina Gaga; Georgios Tsivgoulis
Journal:  Ther Adv Chronic Dis       Date:  2022-02-17       Impact factor: 5.091

5.  Impact of the post-COVID-19 condition on health care after the first disease wave in Lombardy.

Authors:  Pier M Mannucci; Alessandro Nobili; Mauro Tettamanti; Barbara D'Avanzo; Alessia A Galbussera; Giuseppe Remuzzi; Ida Fortino; Olivia Leoni; Sergio Harari
Journal:  J Intern Med       Date:  2022-04-22       Impact factor: 13.068

6.  A primer on Post-COVID-19 conditions and implications for clinical pharmacists.

Authors:  David Cluck; Kelly L Covert; Jamie L Wagner; Daniel B Chastain
Journal:  J Am Coll Clin Pharm       Date:  2022-06-11

Review 7.  Renewed rationale for sex- and gender-disaggregated research: A COVID-19 commentary review.

Authors:  Kelly Thompson; Amy Vassallo; Simon Finfer; Mark Woodward
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.